Literature DB >> 1367052

Optimization of serum-free fermentation processes for antibody production.

H Büntemeyer1, D Lütkemeyer, J Lehmann.   

Abstract

Serum free fermentation procedures of cell cultures have got a wide application in production of biochemicals. But, cells cultured in serum free media in general are more sensitive to changes in culture condition, especially to nutrient limitation. There are no substances from serum which can support the cells when conditions are changing. In this study special attention is directed to amino acid utilization of mouse hybridoma in batch, chemostat and perfusion fermentations. Detailed data are presented which show the considerable difference of amino acid consumption rates in different fermentation modes. Already, in batch mode there are differences of the two investigated mouse hybridoma cell lines, although they are derived from the same myeloma line. In chemostat running at a dilution rate representing maximal growth rate most of the consumption rates are significant higher than in batch. On the other hand, in perfusion mode the rates are lower than in batch. This indicates clearly the different conditions of the fermentation modes. Therefore, it is necessary to develop serum free processes under the desired production conditions. An accurate analysis of the process is strongly recommended.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1367052     DOI: 10.1007/bf00365534

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  6 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

3.  Influence of amino acids on hybridoma cell viability and antibody secretion.

Authors:  V Geaugey; D Duval; I Geahel; A Marc; J M Engasser
Journal:  Cytotechnology       Date:  1989-05       Impact factor: 2.058

4.  Variation of amino acid concentrations in the medium of HU β-IFN and HU IL-2 producing cell lines.

Authors:  R Wagner; T Ryll; H Krafft; J Lehmann
Journal:  Cytotechnology       Date:  1988-02       Impact factor: 2.058

5.  Serum-free growth medium for the cultivation of a wide spectrum of mammalian cells in stirred bioreactors.

Authors:  V Jäger; J Lehmann; P Friedl
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

6.  High-Density culture of mouse-human hybridoma in serum-free defined medium.

Authors:  Y Takazawa; M Tokashiki; H Murakami; K Yamada; H Omura
Journal:  Biotechnol Bioeng       Date:  1988-02-05       Impact factor: 4.530

  6 in total
  25 in total

1.  Optimal medium use for continuous high density perfusion processes.

Authors:  H Büntemeyer; C Wallerius; J Lehmann
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  The medium cycle bioreactor (MCB): monoclonal antibody production in a new economic production system.

Authors:  R Kempken; H Büntemeyer; J Lehmann
Journal:  Cytotechnology       Date:  1991-10       Impact factor: 2.058

3.  Scale up cultivation of primary human umbilical vein endothelial cells on microcarriers from spinner vessels to bioreactor fermentation.

Authors:  S Duvar; J Müthing; H Mohr; J Lehmann
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

4.  Lysis-free separation of hybridoma cells by continuous disc stack centrifugation.

Authors:  H Tebbe; D Lütkemeyer; F Gudermann; R Heidemann; J Lehmann
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

5.  The effects of microcarrier culture on recombinant CHO cells under biphasic hypothermic culture conditions.

Authors:  Jong Hyun Nam; Myriam Ermonval; Susan T Sharfstein
Journal:  Cytotechnology       Date:  2009-05-02       Impact factor: 2.058

6.  Influence of alterations in culture condition and changes in perfusion parameters on the retention performance of a 20 mum spinfilter during a perfusion cultivation of a recombinant CHO cell line in pilot scale.

Authors:  K Iding; D Lütkemeyer; E Fraune; K Gerlach; J Lehmann
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

7.  Endogenous retrovirus particles and their repercussion effects on the growth behaviour of continuous hybridoma cultivation processes.

Authors:  A Hawerkamp; F Gudermann; A Falkenhain; D Luetkemeyer; U Kahmann; J Lehmann
Journal:  Cytotechnology       Date:  2001-10       Impact factor: 2.058

8.  Effects on growth behavior in continuous hybridoma cell cultures: The role of viral contamination.

Authors:  A Hawerkamp; D Lütkemeyer; F Gudermann; A Falkenhain; H Büntemeyer; J Lehmann
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

9.  Related effects of cell adaptation to serum-free conditions on murine EPO production and glycosylation by CHO cells.

Authors:  François Lefloch; Bertrand Tessier; Sébastien Chenuet; Jean-Marc Guillaume; Pierre Cans; Jean-Louis Goergen; Annie Marc
Journal:  Cytotechnology       Date:  2006-12-29       Impact factor: 2.058

10.  The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells.

Authors:  R Heidemann; C Zhang; H Qi; J Larrick Rule; C Rozales; S Park; S Chuppa; M Ray; J Michaels; K Konstantinov; D Naveh
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.